-
EP1465921
European procedure
Extract from the Register of European Patents
EP About this file: EP1465921
| EP1465921 - CORTICOTROPIN RELEASING FACTOR RECEPTOR 2 AGONISTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 01.06.2007 Database last updated on 22.08.2024 | Most recent event Tooltip | 15.08.2008 | Change - representative | published on 17.09.2008 [2008/38] | Applicant(s) | For all designated states THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza Cincinnati, OH 45202 / US | [N/P] |
| Former [2006/30] | For all designated states THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza Cincinnati, Ohio 45202 / US | ||
| Former [2004/42] | For all designated states THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza Cincinnati, Ohio 45202 / US | Inventor(s) | 01 /
ISFORT, Robert, Joseph 2395 Resor Road Fairfield, OH 45014 / US | 02 /
MAZUR, Wieslaw, Adam 3680 Emery Lake Lane Mason, OH 45040 / US | [2004/42] | Representative(s) | Clemo, Nicholas Graham, et al Procter & Gamble Technical Centres Limited Patent Department Rusham Park Whitehall Lane, Egham Surrey TW20 9NW / GB | [N/P] |
| Former [2008/38] | Clemo, Nicholas Graham, et al Procter & Gamble Technical Centres Limited Patent Department Rusham Park Whitehall Lane Egham Surrey TW20 9NW / GB | ||
| Former [2004/42] | Clemo, Nicholas Graham, et al Procter & Gamble Technical Centres Limited Patent Department Rusham Park Whitehall Lane Egham, Surrey TW20 9NW / GB | Application number, filing date | 03703867.6 | 16.01.2003 | [2004/42] | WO2003US01461 | Priority number, date | US20020349117P | 16.01.2002 Original published format: US 349117 P | US20020376337P | 29.04.2002 Original published format: US 376337 P | US20020388895P | 14.06.2002 Original published format: US 388895 P | US20020411988P | 19.09.2002 Original published format: US 411988 P | [2004/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO03062269 | Date: | 31.07.2003 | Language: | EN | [2003/31] | Type: | A2 Application without search report | No.: | EP1465921 | Date: | 13.10.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.07.2003 takes the place of the publication of the European patent application. | [2004/42] | Type: | B1 Patent specification | No.: | EP1465921 | Date: | 26.07.2006 | Language: | EN | [2006/30] | Search report(s) | International search report - published on: | EP | 06.11.2003 | Classification | IPC: | C07K14/575, A61K38/00, A61P21/00, C12N15/11 | [2005/31] | CPC: |
C07K14/57509 (EP,US);
C07K14/575 (KR);
A61K38/16 (KR);
A61P21/00 (EP);
A61P21/02 (EP);
A61P21/04 (EP);
|
| Former IPC [2004/42] | C07K14/575 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR [2004/42] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | Title | German: | AGONISTEN DES CORTICOTROPIN-FREISETZENDEN FAKTOR REZEPTORS 2 | [2004/42] | English: | CORTICOTROPIN RELEASING FACTOR RECEPTOR 2 AGONISTS | [2004/42] | French: | AGONISTES DU RECEPTEUR 2 DU FACTEUR DE LIBERATION DE LA CORTICOTROPINE | [2004/42] | Entry into regional phase | 25.06.2004 | National basic fee paid | 25.06.2004 | Designation fee(s) paid | 25.06.2004 | Examination fee paid | Examination procedure | 18.07.2003 | Request for preliminary examination filed International Preliminary Examining Authority: US | 25.06.2004 | Examination requested [2004/42] | 24.06.2005 | Despatch of a communication from the examining division (Time limit: M06) | 04.01.2006 | Reply to a communication from the examining division | 10.02.2006 | Communication of intention to grant the patent | 06.06.2006 | Fee for grant paid | 06.06.2006 | Fee for publishing/printing paid | Divisional application(s) | EP06117810.9 / EP1724283 | Opposition(s) | 27.04.2007 | No opposition filed within time limit [2007/27] | Fees paid | Renewal fee | 25.06.2004 | Renewal fee patent year 03 | 09.01.2006 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | GR | 27.10.2006 | [2008/21] |
| Former [2008/04] | deleted | ||
| Former [2007/40] | IT | 26.07.2006 | Cited in | International search | [A]WO9732898 (UNIV CALIFORNIA [US]) [A] 1,2,6,8,9,12,13 * page 6 - page 7 * * page 10 - page 11 * * page 16 - page 17; table 1B *; | [A] - LEWIS K ET AL, "Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, June 19, 2001, (20010619), vol. 98, no. 13, ISSN 0027-8424, pages 7570 - 7575, XP002244720 [A] 1,10,12,13 * figure 1; table 1 * DOI: http://dx.doi.org/10.1073/pnas.121165198 | [A] - ECKART KLAUS ET AL, "A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: Implications for the design of agonists and antagonists.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, September 25, 2001, (20010925), vol. 98, no. 20, ISSN 0027-8424, pages 11142 - 11147, XP002244721 [A] 1,2,6,11-13 * page 11144; figure 1; table 1 * DOI: http://dx.doi.org/10.1073/pnas.211424998 | [A] - BEYERMANN MICHAEL ET AL, "A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.", JOURNAL OF MEDICINAL CHEMISTRY, (1996), vol. 39, no. 17, ISSN 0022-2623, pages 3324 - 3330, XP002244722 [A] 1,10,12,13 * page 3325, column R, paragraphs 3,6; tables 1,2 * DOI: http://dx.doi.org/10.1021/jm960116z | [A] - KORNREICH W D ET AL, "ALANINE SERIES OF OVINE CORTICOTROPIN RELEASING FACTOR (OCRF): A STRUCTURE-ACTIVITY RELATIONSHIP STUDY", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1992), vol. 35, no. 10, ISSN 0022-2623, pages 1870 - 1876, XP002030859 [A] 1,10,12,13 * tables I,II * DOI: http://dx.doi.org/10.1021/jm00088a024 | [A] - REYES T M ET AL, "Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, February 27, 2001, (20010227), vol. 98, no. 5, ISSN 0027-8424, pages 2843 - 2848, XP002244723 [A] 1,10,12,13 * figure 1; table 1 * DOI: http://dx.doi.org/10.1073/pnas.051626398 | [A] - RUHMANN ANDREAS ET AL, "Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2beta-selective antisauvagine-30.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, Dec. 22, 1998, (19981222), vol. 95, no. 26, ISSN 0027-8424, pages 15264 - 15269, XP002244724 [A] 1,10,12,13 * figure 1; table 1 * DOI: http://dx.doi.org/10.1073/pnas.95.26.15264 | [A] - ASSIL IMAN Q ET AL, "An oxidation resistant radioligand for corticotropin-releasing factor receptors.", PEPTIDES (NEW YORK), (200107), vol. 22, no. 7, ISSN 0196-9781, pages 1055 - 1061, XP002244725 [A] * the whole document * DOI: http://dx.doi.org/10.1016/S0196-9781(01)00424-7 | [PA] - DAUTZENBERG FRANK M ET AL, "The CRF peptide family and their receptors: Yet more partners discovered.", TRENDS IN PHARMACOLOGICAL SCIENCES, (20020220), vol. 23, no. 2, ISSN 0165-6147, pages 71 - 77, XP002244726 [PA] * the whole document * DOI: http://dx.doi.org/10.1016/S0165-6147(02)01946-6 |